Early use of the NMDA receptor antagonist ketamine in refractory and superrefractory status epilepticus

Critical Care Research and Practice

Volumn 2015, Issue , 2015, Pages

  Zeiler, F A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84947648676     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2015/831260     Document Type: Review

References (30)

1. S. Hocker, E. F. M. Wijdicks, and A. A. Rabinstein, "Refractory status epilepticus: new insights in presentation, treatment, and outcome, " Neurological Research, vol. 35, no. 2, pp. 163-168, 2013.
2. S. Shorvon and M. Ferlisi, "The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol, " Brain, vol. 134, part 10, pp. 2802-2818, 2011.
3. S. E. Hocker, J. W. Britton, J. N. Mandrekar, E. F. Wijdicks, and A. A. Rabinstein, "Predictors of outcome in refractory status epilepticus, " Archives of Neurology, vol. 70, no. 1, pp. 72-77, 2013.
4. S. A. Mayer, J. Claassen, J. Lokin, F. Mendelsohn, L. J. Dennis, and B. F. Fitzsimmons, "Refractory status epilepticus: frequency, risk factors, and impact on outcome, " Archives of Neurology, vol. 59, no. 2, pp. 205-210, 2002.
5. M. Ferlisi and S. Shorvon, "The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy, " Brain, vol. 135, no. 8, pp. 2314-2328, 2012.
6. G. Hunter and G. B. Young, "Status epilepticus: a review, with emphasis on refractory cases, " Canadian Journal of Neurological Sciences, vol. 39, no. 2, pp. 157-169, 2012.
7. W. Löscher, "Mechanisms of drug resistance in status epilepticus, " Epilepsia, vol. 48, supplement s8, pp. 74-77, 2007.
8. G. M. Brophy, R. Bell, J. Claassen et al., "Guidelines for the evaluation andmanagement of status epilepticus, " Neurocritical Care, vol. 17, no. 1, pp. 3-23, 2012.
9. D. Schmidt and S. C. Schachter, "Drug treatment of epilepsy in adults, " The British Medical Journal, vol. 348, Article ID g2546, 2014.
10. T. Z. Deeb, J. Maguire, and S. J. Moss, "Possible alterations in GABA receptor signaling that underlie benzodiazepineresistant seizures, " Epilepsia, vol. 53, supplement 9, pp. 79-88, 2012.
11. H.-J. Feng, G. C. Mathews, C. Kao, and R. L. Macdonald, "Alterations of GABAA-receptor function and allosteric modulation during development of status epilepticus, " Journal of Neurophysiology, vol. 99, no. 3, pp. 1285-1293, 2008.
12. W. Löscher and H. Potschka, "Drug resistance in brain diseases and the role of drug efflux transporters, " Nature Reviews Neuroscience, vol. 6, no. 8, pp. 591-602, 2005.
13. D. G. Fujikawa, "Prolonged seizures and cellular injury: understanding the connection, " Epilepsy and Behavior, vol. 7, supplement 3, pp. S3-S11, 2005.
14. A. Vezzani and T. Granata, "Brain inflammation in epilepsy: experimental and clinical evidence, " Epilepsia, vol. 46, no. 11, pp. 1724-1743, 2005.
15. C. G. Wasterlain and J. W. Y. Chen, "Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs, " Epilepsia, vol. 49, supplement 9, pp. 63-73, 2008.
16. D. G. Fujikawa, "Neuroprotective effect of ketamine administered after status epilepticus onset, " Epilepsia, vol. 36, no. 2, pp. 186-195, 1995.
17. B. S. Martin and J. Kapur, "A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation, " Epilepsia, vol. 49, no. 2, pp. 248-255, 2008.
18. C. Brandt, H. Potschka, W. Löscher, and U. Ebert, "N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy, " Neuroscience, vol. 118, no. 3, pp. 727-740, 2003.
19. L. Yurkewicz, J. Weaver, M. R. Bullock, and L. F. Marshall, "The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury, " Journal of Neurotrauma, vol. 22, no. 12, pp. 1428-1443, 2005.
20. L. B. Stewart, R. Bullock, G. M. Teasdale, and A. Wagstaff, "First observations of the safety and tolerability of a competitive antagonist to the glutamate NMDA receptor (CGS 19755) in patients with severe head injury, " Journal of Neurotrauma, vol. 16, no. 9, pp. 843-850, 1999.
21. F. Dorandeu, V. Baille, J. Mikler et al., "Protective effects of S(+) ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guineapigs, " Toxicology, vol. 234, no. 3, pp. 185-193, 2007.
22. M. B. Pereira, R. L. M. Freitas, M. A. G. Assis et al., "Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats, " Neuroscience Letters, vol. 419, no. 3, pp. 253-257, 2007.
23. R. M. Freitas, F. C. F. Sousa, G. S. B. Viana, and M. M. F. Fonteles, "Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus, " Neuroscience Letters, vol. 408, no. 2, pp. 79-83, 2006.
24. C. M. Loss, S. D. Ćordova, and D. L. de Oliveira, "Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats, " Brain Research, vol. 1474, pp. 110-117, 2012.
25. F. Dorandeu, F. Dhote, L. Barbier, B. Baccus, and G. Testylier, "Treatment of status epilepticus with ketamine, are we there yet?" CNS Neuroscience and Therapeutics, vol. 19, no. 6, pp. 411-427, 2013.
26. A. S. Fix, J. W. Horn, K. A. Wightman et al., "Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex, " ExperimentalNeurology, vol. 123, no. 2, pp. 204-215, 1993.
27. D. Pohl, P. Bittigau, M. J. Ishimaru et al., "N-methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2508-2513, 1999.
28. F. A. Zeiler, J. Teitelbaum, L. M. Gillman, and M. West, "NMDA antagonists for refractory seizures, " Neurocritical Care, vol. 20, no. 3, pp. 502-513, 2014.
29. F. A. Zeiler, J. Teitelbaum, M. West, and L. M. Gillman, "The ketamine effect on ICP in traumatic brain injury, " Neurocritical Care, vol. 21, no. 1, pp. 163-173, 2014.
30. F. A. Zeiler, J. Teitelbaum, M. West, and L. M. Gillman, "The ketamine effect on intracranial pressure in nontraumatic neurological illness, " Journal of Critical Care, vol. 29, no. 6, pp. 1096-1106, 2014.